P
Peter Theissen
Researcher at University of Cologne
Publications - 94
Citations - 3077
Peter Theissen is an academic researcher from University of Cologne. The author has contributed to research in topics: Magnetic resonance imaging & Coronary artery disease. The author has an hindex of 28, co-authored 93 publications receiving 2995 citations.
Papers
More filters
Journal ArticleDOI
Comparison of Low-Dose Dobutamine–Gradient-Echo Magnetic Resonance Imaging and Positron Emission Tomography With [18F]Fluorodeoxyglucose in Patients With Chronic Coronary Artery Disease A Functional and Morphological Approach to the Detection of Residual Myocardial Viability
Frank M. Baer,Eberhard Voth,Christian A. Schneider,Peter Theissen,Harald Schicha,Udo Sechtem +5 more
TL;DR: Viable myocardium is characterized by preserved end-diastolic wall thickness and a dobutamine-inducible contraction reserve, and both parameters should be taken into account to maximize the sensitivity of MRI in the detection of regions with signs of viability on FDG-PET images.
Journal ArticleDOI
Dobutamine Magnetic Resonance Imaging Predicts Contractile Recovery of Chronically Dysfunctional Myocardium After Successful Revascularization
Frank M. Baer,Peter Theissen,Christian A. Schneider,Eberhard Voth,Udo Sechtem,Harald Schicha,Erland Erdmann +6 more
TL;DR: Quantitative assessment of dobutamine-induced SWT in chronic infarcts by MRI is a highly accurate predictor of LV functional recovery, and the presence of significantly reduced DWT reliably indicates irreversible myocardial damage.
Journal ArticleDOI
Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees.
Christoph Reiners,Karl Wegscheider,Harald Schicha,Peter Theissen,Renate Vaupel,Renate Wrbitzky,P.-M. Schumm-Draeger +6 more
TL;DR: The results emphasize the importance of effective sonographic screening to detect early thyroid abnomalities in order to initiate preventive and therapeutic measures to prevent the onset or progression of disease and its sequels.
Journal ArticleDOI
Fluorine-18 fluorodeoxyglucose positron emission tomography and iodine-131 whole-body scintigraphy in the follow-up of differentiated thyroid cancer.
TL;DR: If the Tg level is elevated and 131I WBS is negative, FDG PET can be used to detect lymph node metastases and complements anatomical imaging, andFDG PET cannot be substituted for 131i WBS.
Journal ArticleDOI
Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.
Markus Dietlein,Kerstin Weber,Afschin Gandjour,Detlef Moka,Peter Theissen,Karl W. Lauterbach,Harald Schicha +6 more
TL;DR: The implementation of whole-body PET with a full ring of detectors in the preoperative staging of patients with NSCLC and normal-sized lymph nodes is clearly cost-effective, however, patients with nodal-positive PET results should not be excluded from biopsy.